Stay updated with breaking news from Generation Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Generation Bio Co. (NASDAQ:GBIO – Get Free Report) have received a consensus recommendation of “Hold” from the six analysts that are covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold rating and two have issued a buy rating on the company. The average 1-year price target […]
The global biotechnology market was valued at approximately $1.55 trillion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.96% from 2024 to 2030, reaching a staggering...
Moderna, Inc. beats earnings expectations. Reported EPS is $-3.07, expectations were $-3.56.
Reports first quarter revenues of $167 million, GAAP net loss of $1.2 billion and GAAP diluted EPS of $(3.07)Prepares for launches of RSV vaccine and Spikevax® 2024-2025 formula; reaffirms 2024 expected product sales of approximately $4 billionInitiated three new clinical studies evaluating Moderna's investigational...
MRNA earnings call for the period ending March 31, 2024.